Literature DB >> 23038753

Methylation of RASSF1A gene promoter is regulated by p53 and DAXX.

Hailong Zhang1, Jing He, Jiansha Li, Dan Tian, Lubing Gu, Muxiang Zhou.   

Abstract

Inactivation of the tumor suppressor Ras-association domain family 1 isoform A (RASSF1A) due to epigenetic silencing occurs in a variety of human cancers, and still largely unknown are the regulators and mechanisms underlying RASSF1A gene promoter methylation. Herein, we report that this methylation is regulated by p53 and death-associated protein 6 (DAXX) in acute lymphoblastic leukemia (ALL). We found that p53 bound to the RASSF1A promoter, recruiting DAXX as well as DNA methyltransferase 1 (DNMT1) for DNA methylation, which subsequently resulted in inactivation of RASSF1A in wild-type p53 ALL cells. Although the presence of p53 was required for the recruitment of DAXX and DNMT1 to the RASSF1A promoter, fluctuation in p53 protein levels did not affect the rates of RASSF1A methylation. Conversely, methylation of RASSF1A promoter was critically controlled by DAXX, as the enforced overexpression of DAXX led to enhanced RASSF1A promoter methylation, whereas inhibition of DAXX reduced RASSF1A methylation. Interestingly, we found that the p53/DAXX-mediated RASSF1A methylation regulated murine double minute 2 (MDM2) protein stability in ALL. Our results reveal a novel function for p53 in the methylation of RASSF1A promoter by its interaction with DAXX. Discovery of this mechanism provides new insight into the interactions among the tumor-related factors p53, RASSF1A, DAXX, and MDM2 in cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23038753      PMCID: PMC3528318          DOI: 10.1096/fj.12-215491

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  43 in total

1.  Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression.

Authors:  L B Owen-Schaub; W Zhang; J C Cusack; L S Angelo; S M Santee; T Fujiwara; J A Roth; A B Deisseroth; W W Zhang; E Kruzel
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

2.  RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX.

Authors:  Jennifer S Michaelson; Philip Leder
Journal:  J Cell Sci       Date:  2003-01-15       Impact factor: 5.285

Review 3.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

4.  Daxx, a novel Fas-binding protein that activates JNK and apoptosis.

Authors:  X Yang; R Khosravi-Far; H Y Chang; D Baltimore
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

5.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

Authors:  T Miyashita; J C Reed
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

6.  Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development.

Authors:  J S Michaelson; D Bader; F Kuo; C Kozak; P Leder
Journal:  Genes Dev       Date:  1999-08-01       Impact factor: 11.361

7.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

8.  Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.

Authors:  C Preudhomme; I Dervite; E Wattel; M Vanrumbeke; M Flactif; J L Lai; B Hecquet; M C Coppin; B Nelken; B Gosselin
Journal:  J Clin Oncol       Date:  1995-04       Impact factor: 44.544

9.  Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx.

Authors:  H Y Chang; H Nishitoh; X Yang; H Ichijo; D Baltimore
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

10.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  20 in total

Review 1.  Epigenetic alterations in osteosarcoma: promising targets.

Authors:  Binghao Li; Zhaoming Ye
Journal:  Mol Biol Rep       Date:  2014-02-06       Impact factor: 2.316

2.  Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.

Authors:  Sarandeep S S Boyanapalli; Wenji Li; Francisco Fuentes; Yue Guo; Christina N Ramirez; Ximena-Parades Gonzalez; Douglas Pung; Ah-Ng Tony Kong
Journal:  Pharmacol Res       Date:  2016-11-03       Impact factor: 7.658

Review 3.  p53 shades of Hippo.

Authors:  Noa Furth; Yael Aylon; Moshe Oren
Journal:  Cell Death Differ       Date:  2017-10-06       Impact factor: 15.828

4.  Intact expression status of RASSF1A in acute myeloid leukemia.

Authors:  Davood Zare-Abdollahi; Shamsi Safari; Abolfazl Movafagh; Mojtaba Ghadiani; Sahand Riazi-Isfahani; Mir Davood Omrani
Journal:  Med Oncol       Date:  2013-11-19       Impact factor: 3.064

5.  Distribution and location of Daxx in cervical epithelial cells with high risk human papillomavirus positive.

Authors:  Shuang-yang Tang; Le Li; Yao-lin Li; An-yuan Liu; Min-jun Yu; Yan-ping Wan
Journal:  Diagn Pathol       Date:  2014-01-08       Impact factor: 2.644

6.  The PML-Interacting Protein DAXX: Histone Loading Gets into the Picture.

Authors:  Paolo Salomoni
Journal:  Front Oncol       Date:  2013-06-07       Impact factor: 6.244

7.  The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury.

Authors:  Marilyn Gordon; Mohamed El-Kalla; Yuewen Zhao; Yahya Fiteih; Jennifer Law; Natalia Volodko; Anwar Anwar-Mohamed; Anwar Mohamed; Ayman O S El-Kadi; Lei Liu; Jeff Odenbach; Aducio Thiesen; Christina Onyskiw; Haya Abu Ghazaleh; Jikyoung Park; Sean Bong Lee; Victor C Yu; Carlos Fernandez-Patron; R Todd Alexander; Eytan Wine; Shairaz Baksh
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

8.  Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma.

Authors:  Antonio Zizzi; Maria Alessandra Montironi; Roberta Mazzucchelli; Marina Scarpelli; Antonio Lopez-Beltran; Liang Cheng; Nicola Paone; Paolo Castellini; Rodolfo Montironi
Journal:  Diagn Pathol       Date:  2013-07-02       Impact factor: 2.644

9.  p53-Dependent and cell specific epigenetic regulation of the polo-like kinases under oxidative stress.

Authors:  Alejandra Ward; John W Hudson
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

Review 10.  Epigenetically inactivated RASSF1A as a tumor biomarker.

Authors:  Dora Raos; Monika Ulamec; Ana Katusic Bojanac; Floriana Bulic-Jakus; Davor Jezek; Nino Sincic
Journal:  Bosn J Basic Med Sci       Date:  2021-08-01       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.